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ABSTRACT 26 
Accurate chromosome segregation during mitosis is temporally and spatially coordinated by 27 
fidelity-monitoring checkpoint systems. Deficiencies in these checkpoint systems can lead to 28 
chromosome segregation errors and aneuploidy and promote tumorigenesis. We report that 29 
the TRAF-interacting protein (TRAIP), a ubiquitously expressed nucleolar E3 ubiquitin ligase 30 
important for cellular proliferation, was localized close to mitotic chromosomes. Its functional 31 
inactivation in HeLa cells by siRNAs decreased the time of early mitosis progression from 32 
nuclear envelope breakdown to anaphase onset and increased the percentages of chromosome 33 
alignment defects in metaphase and lagging chromosomes in anaphase compared to control 34 
cells. The decrease in progression time was corrected by the expression of wild-type but not 35 
by an ubiquitin ligase deficient form of TRAIP. TRAIP-depleted cells by-passed taxol-36 
induced mitotic arrest, and significantly reduced kinetochore levels of MAD2 but not of other 37 
spindle checkpoint proteins in the presence of nocodazole. These results imply that TRAIP 38 
regulates the spindle assembly checkpoint, MAD2 abundance at kinetochores and the accurate 39 
cellular distribution of chromosomes. The TRAIP ubiquitin ligase activity is functionally 40 
required for the spindle assembly checkpoint control. 41 
42 
43 
INTRODUCTION 44 
The equal distribution of chromosomal DNA during mitosis is ensured by a highly complex 45 
process in which the control of APC/C (anaphase-promoting complex) activity is crucial 46 
(Foley and Kapoor, 2013; Kops et al., 2005; Pines, 2011). APC/C activity is regulated by the 47 
spindle assembly checkpoint (SAC) proteins MAD1, MAD2, BUBR1, BUB1, BUB3 and 48 
MPS1, which sense whether or not chromosomes are connected in a bi-oriented manner to 49 
opposite spindle poles through microtubules (Foley and Kapoor, 2013; Khodjakov and Pines, 50 
2010; Santaguida and Musacchio, 2009). The strength of the SAC critically depends on the 51 
MAD2 abundance at kinetochores (Collin et al., 2013; Heinrich et al., 2013)). Defects in 52 
chromosome segregation control cause chromosomal instability and aneuploidy, common 53 
characteristics of human solid tumors (Holland and Cleveland, 2012). 54 
Ubiquitination is a highly conserved biochemical process attaching ubiquitin monomers to 55 
proteins (Dikic et al., 2009; Welchman et al., 2005). The TRAF-interacting protein 56 
(TRAIP/TRIP/RNF206) is a RING-type E3-ubiquitin-ligase (Besse et al., 2007), but hitherto 57 
no in vivo substrate has been identified. Ectopically expressed TRAIP interacts with TRAF 58 
proteins and represses NF-B signaling (Besse et al., 2007; Lee and Choi, 1997), although 59 
this might not be physiologically (Chapard et al., 2012). TRAIP is expressed ubiquitously at a 60 
low level (Lee and Choi, 1997; Su et al., 2004) in nucleoli (Zhou and Geahlen, 2009) of 61 
interphase cells but is over-expressed in breast cancer cell lines (Zhou and Geahlen, 2009) and 62 
in basal cell carcinomas (Almeida et al., 2011). 63 
Both TRAIP knock-out mice (Park et al., 2007) and mutants of NOPO (Merkle et al., 2009), 64 
the Drosophila homolog of mammalian TRAIP, die early in development due aberrant 65 
proliferation and mitosis. TRAIP transcription is strongly down-regulated upon induction of 66 
cell cycle exit, and its knock-down decreased proliferation and caused a G1/S phase block in 67 
keratinocytes (Almeida et al., 2011). TRAIP interacts with CYLD (Regamey et al., 2003) and 68 
Syk (Zhou and Geahlen, 2009), two tumor suppressors (Bailet et al., 2009; Bignell et al., 69 
2000; Coopman et al., 2000; Lee et al., 2005; Moroni et al., 2004), and with DNA polymerase 70 
η, which facilitates translesional synthesis after DNA damage (Wallace et al., 2014). 71 
We report that the TRAIP protein preferentially localized around condensed chromosomes in 72 
pro- and metaphase and on chromosomal DNA from anaphase during mitosis. Its functional 73 
inactivation accelerated the progression through early phases of mitosis, reduced MAD2 74 
recruitment to kinetochores and led to increased mitosis defects. Our findings strongly support 75 
the implication of TRAIP in SAC regulation. 76 
  77 
RESULTS AND DISCUSSION 78 
TRAIP preferentially localizes at the periphery of chromosomes in early mitosis 79 
Analysis of endogenous TRAIP expression by immunofluorescence detection in mitotic cells 80 
showed localization around prometaphase and co-localization with anaphase chromosomes 81 
(Fig. 1A). To determine the specificity of the utilized antibody, immune detection of 82 
endogenous TRAIP in HeLa cells was analyzed 24h after transfection with two siRNAs 83 
targeting TRAIP (siTRAIP1 and siTRAIP2) or a scrambled negative control siRNA 84 
(siCTRL). Both TRAIP mRNA and protein levels were reduced to around 30% in TRAIP-85 
depleted compared to control cells (Suppl. Fig. S1A). The immunofluorescence signal of 86 
endogenous TRAIP was observed in the nucleoplasm of either siCTRL- or siTRAIP-treated 87 
cells during interphase (Fig. 1B). After treatment of cells with a short detergent extraction 88 
before fixation, removing soluble proteins (Nalepa et al., 2013), the signal became nucleolar 89 
in control and disappeared in TRAIP-depleted cells. The signal in mitotic cells was localized 90 
close to congressing chromosomes in prometaphase and associated with condensed 91 
chromosomes in anaphase in control but was strongly reduced in siTRAIP- treated cells (Fig. 92 
1C). 93 
To validate further TRAIP localization, a lentiviral vector driving expression of a functional 94 
(Suppl. Fig. S2, (Besse et al., 2007; Zhou and Geahlen, 2009)) TRAIP-GFP was used to infect 95 
HeLa cells stably expressing α-tubulin-mRFP and H2B-CFP. In early mitotic phases cells, 96 
TRAIP-GFP dispersed throughout the cytoplasm and converged at the chromosome periphery 97 
while in later phases it co-localized with chromosomes (Fig. 1D). A small fraction 98 
accumulated during telophase in cytoplasmic particles, probably corresponding to nucleolus-99 
derived foci (NDF) and pre-nucleolar bodies (PNB) (Dundr et al., 1997; Ma et al., 2007; Van 100 
Hooser et al., 2005).  101 
The perichromosomal layer appears in prometaphase and disappears in telophase/cytokinesis 102 
(Hernandez-Verdun and Gautier, 1994; Ma et al., 2007; Van Hooser et al., 2005). Nucleolar 103 
proteins and RNAs bind to the surface of chromosomes at the beginning of mitosis and are 104 
incorporated again into newly formed nucleoli during telophase (Dundr et al., 1997; Van 105 
Hooser et al., 2005). Different biological functions have been assigned to chromosomal 106 
peripheral proteins (CPP) forming the perichromosomal layer (Hernandez-Verdun, 2011; 107 
Hernandez-Verdun and Gautier, 1994; Ma et al., 2007; Matsunaga and Fukui, 2010). Our 108 
analysis identified the nucleolar protein TRAIP as a CPP and prompted us to investigate 109 
TRAIP function in mitosis. 110 
 111 
TRAIP regulates progression through early phases of mitosis  112 
We examined the consequences of silencing TRAIP expression on mitosis duration using 113 
siRNAs and fluorescence time-lapse imaging of HeLa cells expressing H2B-EGFP and α-114 
tubulin-mRFP (Toso et al., 2009), taking nuclear envelope breakdown (NEB) as starting time 115 
t=0min (Meraldi et al., 2004). In siCTRL-transfected cells, the median duration of mitosis 116 
was 116.7min (95% confidence interval (CI) =111.7-123.3min, range from 75 to 275min). 117 
The high variability of mitosis duration was mainly caused by the time between NEB to 118 
anaphase-onset (Lim et al., 2013; Mchedlishvili et al., 2012; Rieder et al., 1994; Toso et al., 119 
2009) which varied from 20 to 200min (median 53.3min, 95% CI=46.7-61.7min). The time 120 
from anaphase to cytokinesis fluctuated only moderately from 45 to 85min (median 63.3min, 121 
95% CI=60-66.7min) (Figs. 2A-D). 122 
The average time of complete mitosis of siTRAIP1 or 2 treated cells was reduced to 96.7min 123 
(95% CI=95-101min) or 90min (95% CI=87.7-91.7min), respectively (Fig. 2A). Although the 124 
duration from anaphase to cytokinesis with siTRAIP1 (range 45 to 95min; median 66.7min, 125 
95% CI=63.3-70min) and siTRAIP2 (range 45 to 80min; median 58.3min, 95% CI=56.7-126 
63.3min) was very similar to control cells, the time from NEB to anaphase-onset was 127 
significantly reduced to 30min (95% CI=28.3-33.3min, range 20 to 75min) with siTRAIP1 128 
and 26.7min (95% CI=26.7-28.3min, range 20 to 85min) with siTRAIP2 (Figs. 2B-C). Ninety 129 
percent of TRAIP-depleted cells accomplished the onset of anaphase within 45min after NEB 130 
compared to only 50% of control cells (Fig. 2E). In the skew-normal frequency distribution of 131 
anaphase-onset times, a first population (peak of the distribution) with rapid and uniform 132 
chromosome congression and a second with longer anaphase-onset times (active spindle 133 
checkpoint) can be distinguished (Meraldi et al., 2004; Rieder et al., 1994). In control siRNA-134 
transfected HeLa cells, the skew normal distribution of anaphase-onset times had a peak 135 
(mode) at 31.8±1.2min whereas in TRAIP-depleted cells a shift to 28.4±0.4min (siTRAIP1) 136 
or 24.2±0.4min (siTRAIP2) was observed (Fig. 2F). The NEB to anaphase-onset time in cells 137 
transduced with siRNA-resistant TRAIP before siRNA transfection was indistinguishable 138 
from the control while a catalytically inactive TRAIP mutant (C25A) failed to rescue (Fig. 139 
2G). Although MAD2 is a frequent siRNA off-target (Hubner et al., 2010; Sigoillot et al., 140 
2012; Westhorpe et al., 2010), expression of MAD2, MAD1, BUB1 and BUB3 remained 141 
unchanged after TRAIP KD (Suppl. Fig. S1B-C). Together with the rescue data it is therefore 142 
unlikely that TRAIP KD phenotypes are caused by off-target effects. These findings 143 
suggested that the ubiquitin ligase TRAIP is implicated in the regulation of NEB to anaphase-144 
onset time. 145 
TRAIP loss enhances chromosome alignment defects and lagging chromosomes. 146 
Since a reduced NEB to anaphase-onset time could induce aberrant chromosome segregation 147 
(Meraldi and Sorger, 2005; Michel et al., 2001; Perera et al., 2007), we examined whether 148 
TRAIP depletion affected chromosome behavior. The number of TRAIP-depleted cells 149 
dividing with a bipolar spindle and giving rise to two living daughter cells was not 150 
significantly different from control cells. Mitotic indexes in siRNA-treated cells were 151 
examined by anti-phospho-Histone H3(Ser28) and anti-α-tubulin immunostaining. Although 152 
mitotic indexes were comparable (Fig. 3A), the percentage of cells in prophase was reduced 153 
by 10 to 20 % in TRAIP-depleted compared to control cells (Fig. 3B), consistent with shorter 154 
NEB to anaphase-onset times. In TRAIP-depleted mitotic cells synchronized by a double-155 
thymidine block the percentage of non-aligned chromosomes at the metaphase plate was 156 
increased compared to the control (38.5±4.9% siRNA#1, 37.1±7.6% siRNA#2, 19.6±7.5% 157 
control; mean±s.d) (Figs. 3C and E). Chromosome segregation errors were detected in mitotic 158 
cells treated with either siTRAIP1 or 2 compared to control cells (15.7±4.5% or 19.5±6.7% 159 
vs. 9.7±2.9%; mean±s.d.) (Figs. 3D and F). As expected, chromosome alignment and 160 
segregation errors were increased in MAD2-depleted cells supporting the reliability of our 161 
data (Figs. 3E-F). In summary, TRAIP down-regulation in HeLa cells leads to chromosome 162 
misalignment and segregation defects. 163 
 164 
TRAIP loss decreases spindle assembly checkpoint function 165 
Our results demonstrated that early mitosis and chromosome behavior are affected in response 166 
to TRAIP KD, suggesting a role of TRAIP in the SAC. To investigate whether TRAIP KD 167 
enabled HeLa cells to bypass the SAC, a taxol-induced mitotic arrest assay (Stegmeier et al., 168 
2007a) assessing mitotic index and nuclear morphology was undertaken. CYLD and MAD2 169 
siRNAs were used as controls for mitotic entry delay and SAC bypass (Draviam et al., 2007; 170 
Meraldi et al., 2004; Stegmeier et al., 2007a; Stegmeier et al., 2007b). Only 13±8% 171 
(mean±s.d.) of MAD2- or 51±15% of CYLD-depleted cells were mitotic (Fig. 4A-B) 172 
(Stegmeier et al., 2007b) compared to control cells (74±7%). In TRAIP depleted cells a 173 
reduced mitotic index (siRNA#1, 52±16%; siRNA#2, 53±8%) (Fig. 4B) and multilobed 174 
nuclear morphology (Stegmeier et al., 2007a; Stegmeier et al., 2007b), similarly to MAD2 175 
siRNA treated cells (Figs. 4A and C), was found, demonstrating that loss of TRAIP led to a 176 
checkpoint-bypass phenotype. However, TRAIP depletion leads to a smaller effect than 177 
MAD2 knock-down. Whether this reflects a phenotypic difference or is due to differences in 178 
the degree of mRNA knockdown remains to be seen. Our data indicated that TRAIP depletion 179 
was less effective compared to MAD2 knockdown (Suppl. Fig. S1A). To summarize, loss of 180 
TRAIP reduced mitotic arrest in response to the spindle poison taxol, hence led to the bypass 181 
of the SAC.  182 
 183 
TRAIP depletion decreases Mad2 levels at unattached kinetochores.  184 
Expression and/or localization of SAC proteins are finely modulated to regulate APC/C 185 
activity (Musacchio and Salmon, 2007) in a dose-dependent manner (Collin et al., 2013; 186 
Heinrich et al., 2013). The robustness of the SAC is in part determined by the MAD2 amount 187 
recruited to kinetochores. To elucidate whether TRAIP deficiency is affecting the kinetochore 188 
localization of SAC proteins, we performed immuno-fluorescence detection of MAD1, 189 
MAD2, BUB1, and BUBR1 proteins in TRAIP siRNA-treated cells (Fig. 4D-E). SAC 190 
proteins were correctly positioned at unattached kinetochores marked by an anti-CREST 191 
antibody in prometaphase cells. However, the amount of MAD2 recruited to the kinetochores 192 
was significantly reduced in TRAIP-depleted cells compared to control cells (70.2%±10.1% 193 
siRNA#1, 68.5%±9.9% siRNA#2, 100%±12.8% control; mean±s.d.) (Fig. 4E-F). This might 194 
be physiologically relevant since a reduction of 20% in MAD2 levels is sufficient to impair 195 
SAC activity in yeast (Heinrich et al., 2013).  196 
In summary, we have demonstrated that TRAIP changes its predominantly nucleolar 197 
localization in interphase cells to the perichromosomal layer in mitosis. The decrease in 198 
progression time from NEB to anaphase-onset and in the binding of MAD2 to kinetochores in 199 
TRAIP-depleted cells leading to misalignment and segregation errors of chromosomes 200 
identified TRAIP as a novel regulator of SAC activity in an ubiquitin-ligase-dependent 201 
manner. Our findings most likely explain the cell death in TRAIP KO mice and NOPO 202 
mutants in Drosophila embryos since inaccurate chromosome segregation negatively 203 
impinges on the life of normal cells. The elucidation of how TRAIP functions at the 204 
molecular level to regulate the SAC awaits identification of its substrates and interaction 205 
partners. 206 
  207 
MATERIALS AND METHODS 208 
 209 
Cell culture 210 
Cells were cultured in DMEM containing 10% fetal bovine serum and appropriate antibiotics 211 
(G418, 200 ug/ml; puromycin, 0.25 ug/ml). Cells were synchronized by a double-thymidine 212 
(2mM) block. Transfection of siRNAs was performed after the first thymidine treatment.  213 
 214 
Plasmids and lentivirus 215 
TRAIP cDNA was amplified from a human cDNA library and cloned into pEGFP-N3 216 
(Clontech) or the lentiviral vector pCDH-CMV-MCS-EF1-Hygro (BioCat). TRAIP cDNAs 217 
with the C25A mutation or resistance to siRNAs were constructed by PCR amplification. 218 
PCR products were verified by sequencing. LV-CFP expressing H2B-CFP was purchased 219 
(Addgene #25998). Cells were infected (MOI of 10) with lentivirus (Almeida et al., 2011) and 220 
selected with 800ug/ml hygromycin. 221 
 222 
Protein extractions and TRAIP auto-ubiquitination 223 
Proteins were extracted by cell lysis in 1% SDS/phosphate-buffered saline. For immunoblots 224 
the following antibodies were used: GFP (Clontech), actin (Sigma), rabbit-anti-TRAIP 225 
(Abcam), goat-anti-TRAIP antibody (Imgenex), MAD2 (Covance) and HA (Santa Cruz 226 
Biotechnology). TRAIP auto-ubiquitination was carried out as described (Almeida et al., 227 
2008). Signals from immunoblots were captured by LAS4000 (GE) and analysed by ImageJ. 228 
 229 
RNA interference 230 
siRNA targeting human TRAIP mRNA (NM_005879.2) and Control siRNA (Origene), 231 
hCYLD (Draviam et al., 2007; Sun et al., 2010), and hMAD2 (Uzunova et al., 2012) were 232 
transfected into cells at 30nM final concentration using INTERFERin (Polyplus).  233 
 234 
Live-cell imaging and immunofluorescence analysis 235 
Experiments were performed at 37°C/5%CO2 in cell culture chambers (MatTek) in phenol 236 
red-free medium. For time-lapse experiments 24h after siRNA transfection, images were 237 
recorded every 5 min for 16h using a 20x Plan-NeofluarNA0.5 objective on a Axio 238 
Observer.Z1 microscope (Zeiss). Confocal live-cell imaging experiments were performed 239 
using 63x/1.40 oil objective on a LSM700 confocal laser scanning microscope (Zeiss). The 240 
following antibodies were used for immunofluorescence: GFP (Clontech), TRAIP (Abcam), 241 
phospho-Histone-H3(Ser28) (Cell Signaling Technology), tubulin (Sigma), nucleolin C23 242 
(Santa Cruz Biotechnology), MAD1 (Meraldi et al., 2004), MAD2 (Bethyl Laboratories), 243 
BUB1 (Klebig et al., 2009), BUBR1 (Klebig et al., 2009), and CREST (Klebig et al., 2009). 244 
Images were analyzed using ImageJ. Kinetochore MAD2 levels were quantified as described 245 
(McClelland et al., 2007).  246 
 247 
Taxol assay 248 
The taxol assay inHeLa cells was carried out as described (Stegmeier et al., 2007a) except for 249 
DNA staining with Dapi. MosaiX images were acquired using 20xobjective on a Axio Imager 250 
microscope (Zeiss) equipped with DIC and Dapi filters. Cells were scored using ImageJ. 251 
 252 
RNA isolation and qRT-PCR analysis 253 
RNA was purified using RNeasy Kit (Qiagen) and cDNA was synthesized using Primescript-254 
RT Kit (TakaRa). Quantitative PCR analysis was performed (Almeida et al., 2011) using 255 
RPL13A (endogenous reference), TRAIP, CYLD, MAD1, Bub1B, Bub3 (Qiagen) or MAD2 256 
(Universal Probe Library, Roche) primers. 257 
 258 
Statistical analyses 259 
Statistical significance, denoted as * p0.05, ** p<0.01, *** p<0.001,**** p<0.0001, was 260 
calculated using 1way-ANOVA followed by Tukey’s multiple comparisons test or 2way-261 
ANOVA followed by Tukey-Kramer's Post Hoc test (GraphPad Prism6).  262 
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  427 
Figure Legends 428 
Fig. 1: Endogenous and ectopic TRAIP is a chromosomal peripheral protein during 429 
mitosis. (A) Confocal images of mitotic HeLa cells immuno-stained with anti-TRAIP 430 
antibody (green). (B-C) Confocal images of HeLa cells in interphase (B) or mitosis (C) 431 
immuno-stained for endogenous TRAIP (red) and α-tubulin (green) 24h after treatment with 432 
the indicated siRNAs. Extraction was carried out with 0.1% Triton X-100 for 2 min before 433 
fixation (B). The settings for confocal imaging were identical within experiments. Scale bar = 434 
5µm. DNA was marked with Dapi (blue). (D) Confocal images of living HeLa cells stably 435 
expressing α-tubulin-mRFP (red), H2B-CFP (blue) together with TRAIP-GFP (green). PNB 436 
and NDF are marked by grey and white arrowheads, respectively. Scale bars = 5µm. 437 
 438 
Fig. 2: TRAIP depletion decreased the NEB to anaphase time. (A-C) Scatter plot (median 439 
with inter-quartile range) of times for full mitosis (A), NEB to anaphase onset (B), anaphase 440 
onset to cytokinesis (C) in siRNA-treated HeLa cells. N=3 independent experiments, n=225 441 
cells. (D) Successive frames from live-cell movies. Scale bar = 5µm. (E) Cumulative 442 
frequency plots of anaphase-onset times with NEB=0 min. (N=3, n=225). (F) Frequency 443 
distribution of anaphase-onset times (N=3, n=225). (G) Rescue of the decreased NEB to 444 
anaphase-onset time by the expression of siRNA-resistant wild-type but not by catalytically 445 
inactive (ci, C25A) TRAIP. Median with inter-quartile range; N=3, n=180. 446 
 447 
Fig. 3: TRAIP depletion leads to chromosome alignment defects and lagging 448 
chromosomes. (A) Mitotic index of siRNA-treated HeLa cells (N=3, n=7000) (B) 449 
Distribution of siRNA-treated HeLa cells in the different phases of mitosis (N=3, n=250). (C-450 
D) Representative images of siRNA-transfected HeLa cells in metaphase (C) and anaphase 451 
(D). Arrows show unaligned (C) or lagging chromosomes (D). Scale bar = 5µm. (E) Fraction 452 
of cells with unaligned chromosomes at metaphase plate (N=3, n>100, for siCTRL, siTRAIP1 453 
and siTRAIP2; N=2, n=14 (siMAD2) and 60 (siCYLD). (F) Fraction of cells with segregation 454 
errors in anaphase (N=3, n>150, for siCTRL, siTRAIP1 and siTRAIP2; N=2, n=69 (siMAD2) 455 
and 45 (siCYLD). Results in (A-B) are shown as mean±s.e.m. 456 
 457 
Fig. 4: TRAIP regulates the spindle checkpoint by reducing MAD2 at unattached 458 
kinetochores. (A) Representative images of siRNA-transfected HeLa cells treated with 100 459 
nM taxol for 24 hours. Scale bar = 30µm. (B-C) The percentage of mitotic cells (B) and cells 460 
with either multilobed or interphase nuclei (C) was counted by cell rounding in DIC 461 
microscopy and Dapi staining. Results are represented as mean±s.e.m. (N=4, n>2700, for 462 
siCTRL, siTRAIP1 and siTRAIP2; N=2, n=400 for siMAD2 and siCYLD). (D-E) Confocal 463 
images of siRNA-treated HeLa cells immuno-stained for CREST (red), and either MAD1, 464 
MAD2, BUB1 (green) or BUBR1 (purple). Cells in (E) were treated with nocodazole 465 
(1µg/ml) for 1h prior to analysis. Scale bar = 5μm. (F) Scatter plot of MAD2 intensities at 466 
single kinetochores in nocodazole-treated cells shown in (E). Quantification of MAD2 levels 467 
relative to the CREST signal (median with inter-quartile range). The total mean signal for 468 
MAD2 in control cells was normalised to 1.  469 
 470 
Supplementary Figures 
 
Supplementary Figure S1: RNA interference in HeLa cells. Analysis of mRNA (A-C) and 
protein (A-B) levels were analyzed by quantitative PCR and immunoblot 24h after siRNA-
transfection of HeLa cells. Results are reported as representative mean±s.d. of 2 or more 
independent experiments. 
 
Supplementary Figure S2: TRAIP-GFP is a functional fusion protein. (A) Western blot of 
TRAIP-GFP (IB: TRAIP) and HA-ubiquitin (IB: HA) after immunoprecipitation of TRAIP-GFP 
from 293T cells transfected with pCMV-TRAIPGFP and/or pHA-Ub. B) Confocal images of 
cells after immuno-staining for GFP (green) and nucleolin (red). Scale bar = 10μm.  
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